✨ Medicine Distribution Consents
116 NEW ZEALAND GAZETTE, No. 5 15 JANUARY 2009
Schedule
Product: Mencevax ACWY vaccine
Active Ingredients: Neisseria meningitidis, group A 50μg
Neisseria meningitidis, group C 50μg
Neisseria meningitidis, group W135 50μg
Neisseria meningitidis, group Y 50μg
Dosage Form: Powder for injection
Diluent
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Biologicals SA, Rixensart, Belgium
Dated this 9th day of January 2009.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go414
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Aldurazyme
Active Ingredient: Laronidase 0.58mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: BioMarin Pharmaceutical Inc, Novato, California, United States of America
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 9th day of January 2009.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go417
Renewal of Provisional Consent to the Distribution of a Medicine
Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
Schedule
Product: Proleukin
Active Ingredient: Aldesleukin 18MIU
Dosage Form: Powder for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Biotech Partnership Inc, Emeryville, California, United States of America
Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United Kingdom
Note: This renewed consent is valid for two years from 27 January 2009.
Product: Proleukin
Active Ingredient: Aldesleukin 9MIU
Dosage Form: Powder for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Biotech Partnership Inc, Emeryville, California, United States of America
Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United Kingdom
Note: This renewed consent is valid for two years from 27 January 2009.
Dated this 9th day of January 2009.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go416
Next Page →
✨ LLM interpretation of page content
🏥 Consent to the Distribution of a New Medicine - Mencevax ACWY
🏥 Health & Social Welfare9 January 2009
Medicines Act 1981, Vaccine, Distribution Consent, GlaxoSmithKline
- JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate
🏥 Provisional Consent to the Distribution of a New Medicine - Aldurazyme
🏥 Health & Social Welfare9 January 2009
Medicines Act 1981, New Medicine, Distribution Consent, Pharmacy Retailing
- JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate
🏥 Renewal of Provisional Consent to the Distribution of a Medicine - Proleukin
🏥 Health & Social Welfare9 January 2009
Medicines Act 1981, Medicine Renewal, Distribution Consent, Novartis
- JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate
NZ Gazette 2009, No 5